ESMO Virtual Preceptorship on Breast Cancer 2021: November
![ESMO-Virtual-Preceptorship-Breast-Cancer-2021-1000x250-November](/var/esmo/storage/images/media/esmo/meetings/2021/_preceptorships/images/esmo-virtual-preceptorship-breast-cancer-2021-1000x250-november/8421761-1-eng-GB/esmo-virtual-preceptorship-breast-cancer-2021-1000x250-november.jpg)
- Start date
- 22 Nov 2021
- End date
- 23 Nov 2021
- Location
- Virtual, GMT +8
Learning objectives
- To learn about genetic testing and management of BRCA carriers
- To learn about the biology of breast cancer and its implications in the management of this disease
- To learn about the standard of care management of early, locally advanced, and metastatic breast cancer in surgery, radiation therapy and systemic therapy
- To understand the crucial role of multidisciplinary care in the management of breast cancer
Accreditation
The programme of this virtual event has been accredited with 7 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-chairs
- Rebecca A. Dent, Singapore
- Peter Schmid, United Kingdom